Loading clinical trials...
Loading clinical trials...
This is an observational study in which only data from babies with retinopathy of prematurity (ROP) who are being treated with aflibercept (Eylea) in prefilled syringe (PFS) using a paediatric dosing ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bayer
NCT07093255 · Retinopathy of Prematurity (ROP)
NCT07247474 · Neonates and Preterm Infants, Cardiopulmonary
NCT06940713 · Neonates and Preterm Infants, Neonates or Premature Babies
NCT05558059 · Retinopathy of Prematurity
NCT06092463 · Preterm Infants, Term Infants, and more
Many locations
Multiple Locations
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions